Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global topical wound agents market 3600 synopsis, 2018 – 2032
2.1.1 Regional trends
2.1.2 Product trends
2.1.3 Drug type trends
2.1.4 Application trends
2.1.5 Distribution channel trends
2.1.6 End-use trends
Chapter 3 Topical Wound Agents Industry Insights
3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Rising prevalence of chronic wounds
3.4.1.2 Advancements in wound care technologies
3.4.1.3 Increasing number of surgical procedures
3.4.1.4 Rising awareness regarding wound management
3.4.2 Industry pitfalls & challenges
3.4.2.1 Availability of alternative therapies
3.4.2.2 Stringent regulatory requirements
3.5 Growth potential analysis
3.5.1 By product
3.5.2 By drug type
3.5.3 By application
3.5.4 By distribution channel
3.5.5 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023
Chapter 5 Topical Wound Agents Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Creams
5.3 Gels
5.4 Sprays
5.5 Other products
Chapter 6 Topical Wound Agents Market Size and Forecast, By Drug Type, 2018-2032 (USD Million)
6.1 Key trends, by drug type
6.2 Antiseptics
6.3 Antibiotics
6.4 Nonsteroidal anti-inflammatory agents (NSAIDS)
6.5 Other drug types
Chapter 7 Topical Wound Agents Market Size and Forecast, By Application, 2018-2032 (USD Million)
7.1 Key trends, by application
7.2 Chronic wounds
7.2.1 Diabetic foot ulcers
7.2.2 Pressure ulcers
7.2.3 Venous leg ulcers
7.2.4 Other chronic wounds
7.3 Acute wounds
7.3.1 Surgical & traumatic
7.3.2 Burns
Chapter 8 Topical Wound Agents Market Size and Forecast, By Distribution Channel, 2018-2032 (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 E-commerce
Chapter 9 Topical Wound Agents Market Size and Forecast, By End-use, 2018-2032 (USD Million)
9.1 Key trends, by end-use
9.2 Hospitals
9.3 Clinics
9.4 Other end-users
Chapter 10 Topical Wound Agents Market Size and Forecast, By Region, 2018-2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 Smith & Nephew Plc
11.2 Teva Pharmaceutical Industries Ltd.
11.3 Molnlycke Health Care AB
11.4 Arch Therapeutics, Inc.
11.5 Mylan N.V.
11.6 AstraZeneca
11.7 Osiris Therapeutics, Inc.
11.8 3M Company
11.9 Coloplast A/S
11.10 Medline Industries, Inc.
11.11 B. Braun Melsungen AG
11.12 Integra LifeSciences Corporation
11.13 Paul Hartmann AG
11.14 SERDA Therapeutics
11.15 Bausch Health Companies Inc.
